- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: Einhaus, J., Pecher, A., Asteriti, E., Schmid, H., Secker, KA., Duerr-Stoerzer, S., Keppeler, H., Klein, R., Schneidawind, C., Schneidawind, D., 2020. Inhibition of effector B cells by ibrutinib in systemic sclerosis. Arthritis Res Ther 22:66. https://doi.org/10.1186/s13075-020-02153-8
Tübingen, Universität Tübingen, Dissertation, 2021
- Keyword
-
Patients
B cells
Systemic scleroderma
- Event
-
Veröffentlichung
- (where)
-
Tübingen
- (who)
-
Universitätsbibliothek Tübingen
- (when)
-
2022
- Creator
- Contributor
-
Schneidawind, Dominik
- URN
-
urn:nbn:de:bsz:21-dspace-1234622
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:43 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Einhaus, Jakob Franz
- Schneidawind, Dominik
- Universitätsbibliothek Tübingen
Time of origin
- 2022
Other Objects (12)
Mapping of Disease Severity in Patients with Systemic Sclerosis
Altered ocular microvasculature in patients with systemic sclerosis and very early disease of systemic sclerosis using optical coherence tomography angiography
Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis
The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
Immunosuppressive therapy after autologous hematopoietic stem cell transplantation in systemic sclerosis patients — high efficacy of Rituximab
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
IgG+ memory B cell and IgG+ plasma cell antibodies in patients with systemic sclerosis
New insight on the Xq28 association with systemic sclerosis
Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis
Systemic effects of cisternal lavage in patients with aneurysmal subarachnoid hemorrhage
Mapping of Disease Severity in Patients with Systemic Sclerosis
Altered ocular microvasculature in patients with systemic sclerosis and very early disease of systemic sclerosis using optical coherence tomography angiography
Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis
The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
Immunosuppressive therapy after autologous hematopoietic stem cell transplantation in systemic sclerosis patients — high efficacy of Rituximab
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
IgG+ memory B cell and IgG+ plasma cell antibodies in patients with systemic sclerosis
New insight on the Xq28 association with systemic sclerosis
Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis
Systemic effects of cisternal lavage in patients with aneurysmal subarachnoid hemorrhage
Mapping of Disease Severity in Patients with Systemic Sclerosis
Altered ocular microvasculature in patients with systemic sclerosis and very early disease of systemic sclerosis using optical coherence tomography angiography
Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis
The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
Immunosuppressive therapy after autologous hematopoietic stem cell transplantation in systemic sclerosis patients — high efficacy of Rituximab
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
IgG+ memory B cell and IgG+ plasma cell antibodies in patients with systemic sclerosis
New insight on the Xq28 association with systemic sclerosis
Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis